CXCL12 and Hyperglycemia: To confirm whether GLC could block the CXCR4 expression independent of hyperglycemia, AC16 cardiomyocyte cells were treated with CXCR4 agonist SDF1 at 50 ng/mL which showed increased expression of CXCR4 in these cells (Figure 8).